|   | 
        
            
         | 
          | 
        
        
        
            | 
                
             | 
         
        
             | 
         
        
            
            
            
  
    
	  | 
   
  
    
        
          |   | 
          
              
                | 
                    °í·Á°Á¤  KOREAN GINSENG TONIC[Amomum Fruit , Astragalus Root , Cistanchis Herba , Cynanchi wolfordi radix , Epimedium Herb 10% ethanol fl  
                    
                 | 
               
              
                | 
                     ÀϹÝÀǾàǰ | ¹Ì»ý»ê  
                        
                    	
                    
                 | 
               
              
                | 
					  
                  
				  
                 | 
               
              
              
              
              
              |   |  
              
                
                    
                        | 
                      ¾Ë¸²:  | 
                      µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. | 
                     
                    | 
               
            
              
                
                   
                   
                   
                   
		   
                 | 
               
              
                | 
                  
                  
                 | 
               
              | 
            | 
         
       
       | 
   
    |  
  
    | 
      
     | 
     
  |  
                              
                                  | 
                                   | 
                               
            
            
                
            
            
              
            
                            
              
                                                     
            
            
   |  
  
    | 
      
     | 
   
   
     | 
   
    
   
    | 
       
        À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
        ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
        À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
        ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
       
     | 
   
  
     | 
   
   
  
    
      
	
	  
	     |  
	    
	      
	        
            
                | Çã°¡Á¤º¸ | 
                         
	         
	       | 
	     
	     |  
	    
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
   
    û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå  »óÇÑ±Ý¾× | 
    
      
      
            ºñ±Þ¿©
          
        
      
    
    
      
     [»óº´ÄÚµåÁ¶È¸]
      
     [Áúº´ÄÚµåÁý ´Ù¿î·Îµå]
     [¿ì¸®Áý°Ç°ÁÖÄ¡ÀÇ ¹Ù·Î°¡±â]
     | 
   
   
    | ºü¸¥Á¶È¸ | 
    
      
     |   
   
  
  
   
    | Á¦Ç°¼º»ó | 
    
      ÀÎ»ï Æ¯À¯ÀÇ ³¿»õ¿Í °¨¹Ì°¡ ÀÖ´Â °¥»ö Á¡Á¶¼º ¾×ü  
      
	    [Á¦ÇüÁ¤º¸ È®ÀÎ]
     |   
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
    | º¸°ü¹æ¹ý | 
    ±â¹Ð¿ë±â | 
   
  
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
      
        [Á¶È¸]
     | 
      
  
  
  
  
   
    | È¿´ÉÈ¿°ú | 
    
    [ÀûÀÀÁõ º° °Ë»ö] 
     
    
     
	 
      º¸Ç÷°Àå, ÇÇ·Îȸº¹, Á¤·ÂÁõÁø, ÀϹÝÇã¾à, Áߺ´ÈÄÀÇ È¸º¹±âȯÀÚ, °¢Á¾ºóÇ÷, ¼øÈ¯ºóÇ÷, ¼øÈ¯ÀåÇØ, ºÎÁ¤¸Æ,  ½Ä¿åºÎÁø, ¼ÒȺҷ®, °£±â´ÉÀåÇØ, ¿µ¾çºÎÁ·, ¹ßÀ°ºÎÁø, Á¤½Å°ú·Î,±â¾ï·Â°¨Åð,  ½Å°æ¼è¾à, ÀÓ»êºÎ,  ¿ù°æºÒ¼ø, ¿îµ¿ÀüÈÄ, ½Åü¼è¾à, ºóÇ÷½Ç¾È, Á¤½Å°ï±Ç, »êÀü»êÈÄ, º´ÈÄȸº¹
      
      
     | 
   
  
  
  
  
  
  
  
  
    
  
  
   
    | ¿ë¹ý¿ë·® | 
    
      * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù. 
    
     
      
      
     [󹿾à¾î] 
      ¼ºÀÎ 1ȸ 5-10ml,  ¼Ò¾Æ´Â ¼ºÀÎÀÇ 1/2, 5¼¼ ÀÌÇÏ´Â ¼ºÀÎÀÇ 1/4À» 1ÀÏ 3ȸ ½ÄÀü, ½ÄÈÄ¿¡ ±×´ë·Î ¶Ç´Â È¥¼ö, ¿ìÀ¯¿¡ Ÿ¼ º¹¿ë     
      	    
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
   
    | Àû¿ë»óÀÇ ÁÖÀÇ | 
    ÀÌ ¾à¿¡ ÷°¡Á¦·Î  ÇÔÀ¯µÈ Ä«¶ó¸á¿¡ ÀÇÇÏ¿© ¾Ë·¹¸£±â¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¹Ç·Î ÀÌ ¼ººÐ¿¡ °ú¹ÎÇϰųª ¾Ë·¹¸£±â Àü·ÂÀÌ ÀÖ´Â »ç¶÷Àº º¹¿ëÀü¿¡ ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »óÀÇ ÇÒ °Í | 
   
  
  
  
  
  
  		
  
  
   
    | º¸°ü ¹× Ãë±Þ»óÀÇ ÁÖÀÇ | 
    ±â¹Ð¿ë±â | 
   
  	
  
  
  
  
  
  
  
      							
 
 |  
	   
	 
	
	  
       |  
	    
	      
	        
            
                | Á¤º¸¿ä¾à | 
                 
	         
	       | 
	           	    
	     |  
	    | 
  
    µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
    
  
  
    
  
   |  
	   
	 
	
	  
       |  
	    
	      
	        
            
                | ÄÚµå ¹× ºÐ·ùÁ¤º¸ | 
                 
	         
	       | 
	           	    
	     |  
	    | 	 |  
	   
	 
	
	  
       |  
	    
	      
	        
            
                | Á¦Ç°Á¤º¸ | 
                             
	         
	       | 
	           	  
	     |  
	     |  
	   
	 
	
	  
       |  
	    
	      
	        
            
                | º¹¾àÁ¤º¸ | 
                             
	         
	       | 
	           	  
	     |  
	    
  
    | Ç׸ñ | 
    ³»¿ë | 
   
   
    | LACTmed ¹Ù·Î°¡±â | 
    
      
        [¹Ù·Î°¡±â]
     | 
     
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
       
     | 
     
  
  
       
  
                                                          															
  
   
  
  
   
    | ÀӺο¡´ëÇÑÅõ¿© | 
    
      
      
        
	      
	      
	        | *  | 
	        
	          ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù. 
	         | 
	         
	       
	       | 
	   
	  
	    |   | 
	   
	  
	    
	      FDA : Cµî±Þ 
				        
				         (urea; )
				        
	   | 
	  
	  
	  
	     
	     
	     
	     
	     
	     
	   | 
	 
	
	  
	      
	      
	        | *  | 
	        
	          »ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
	         | 
	         
	      
	        | *  | 
	        
	          ¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
	         | 
	         
	       
	   | 
	 
       
     | 
   
  
  
  	   
  
  	   
  
  	   
  
  
  
  
  
  
  
  
   
    | º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ | 
    
      [º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
     | 
   
  	
  
  
  	
  
  
  
   
    | º¸°ü»ó ÁÖÀÇ | 
    
      
    	
     | 
   
  
  
   
    | Á¶Á¦½Ã ÁÖÀÇ | 
    
      
    	
     | 
      
 
 |  
	   
	 
	
	  
       |  
	    
	      
	        
            
                | ½É»çÁ¤º¸ | 
                             
	         
	       | 
	           	  
	     |  
	     |  
	   
	   
	
	  
       |  
	    
	      
	        
            
                | ÇмúÁ¤º¸ | 
                             
	         
	       | 
	           	  
	     |  
	    
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
    | DUR (ÀǾàǰ»ç¿ëÆò°¡) | 
    º´¿ë±Ý±â :
     
	 °í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
	 
	  [»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]										
	  ¿¬·É´ë±Ý±â :
      °í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
      
       [¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
       
       
        
        
     | 
   
  
   
    | µ¶¼ºÁ¤º¸ | 
    Ethanol¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
Urea¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
  Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do  | 
   
  
   
    | Mechanism of Action | 
    
       ethanol¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.
  Ginseng¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Not Available 
     | 
   
  
   
    | Pharmacology | 
     
       ethanol¿¡ ´ëÇÑ Pharmacology Á¤º¸ Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations.
  Ginseng¿¡ ´ëÇÑ Pharmacology Á¤º¸ Not Available 
     | 
   
  
   
    | Metabolism | 
    
       ethanol¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 2E1 (CYP2E1)
  Ginseng¿¡ ´ëÇÑ Metabolism Á¤º¸ # Phase_1_Metabolizing_Enzyme:Cytochrome P450 1A1 (CYP1A1) 
     | 
   
  
   
    | Half-life | 
    
       ethanol¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ Not Available
  Ginseng¿¡ ´ëÇÑ ¹Ý°¨±â Á¤º¸ Not Available 
     | 
   
  
   
    | Absorption | 
    
       ethanol¿¡ ´ëÇÑ Absorption Á¤º¸ Rapidly absorbed.
  Ginseng¿¡ ´ëÇÑ Absorption Á¤º¸ Not Available 
     | 
   
  
   
    | Biotransformation | 
    
       ethanol¿¡ ´ëÇÑ Biotransformation Á¤º¸ Hepatic. Metabolized by cytochrome P450 enzyme CYP2E1.
  Ginseng¿¡ ´ëÇÑ Biotransformation Á¤º¸ Not Available 
     | 
   
  
   
    | Toxicity | 
    
       ethanol¿¡ ´ëÇÑ Toxicity Á¤º¸ Oral, rat LD50: 5628 mg/kg. Symptoms and effects of overdose include nausea, vomiting, CNS depression, acute respiratory failure or death and with chronic use, severe health problems, such as liver and brain damage.
  Ginseng¿¡ ´ëÇÑ Toxicity Á¤º¸ Not Available 
     | 
   
  
   
    | Drug Interactions | 
    
       ethanol¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available
  Ginseng¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Amphetamine	Decreased anorexic effect, may increase psychotic symptomsBenzphetamine	Decreased anorexic effect, may increase psychotic symptomsDexfenfluramine	Decreased anorexic effect, may increase psychotic symptomsDiethylpropion	Decreased anorexic effect, may increase psychotic symptomsFenfluramine	Decreased anorexic effect, may increase psychotic symptomsMazindol	Decreased anorexic effect, may increase psychotic symptomsMethamphetamine	Decreased anorexic effect, may increase psychotic symptomsPhendimetrazine	Decreased anorexic effect, may increase psychotic symptomsDextroamphetamine	Decreased anorexic effect, may increase psychotic symptomsPhenmetrazine	Decreased anorexic effect, may increase psychotic symptomsPhentermine	Decreased anorexic effect, may increase psychotic symptomsPhenylpropanolamine	Decreased anorexic effect, may increase psychotic symptomsTranylcypromine	Possible severe adverse reaction with this combinationPhenelzine	Possible severe adverse reaction with this combinationIsocarboxazid	Possible severe adverse reaction with this combinationPargyline	Possible severe adverse reaction with this combinationBromocriptine	The phenothiazine decreases the effect of bromocriptineCisapride	Increased risk of cardiotoxicity and arrhythmiasGatifloxacin	Increased risk of cardiotoxicity and arrhythmiasGrepafloxacin	Increased risk of cardiotoxicity and arrhythmiasGuanethidine	he agent decreases the effect of guanethidineLevofloxacin	Increased risk of cardiotoxicity and arrhythmiasTerfenadine	Increased risk of cardiotoxicity and arrhythmiasSparfloxacin	Increased risk of cardiotoxicity and arrhythmiasRivastigmine	Possible antagonism of actionDonepezil	Possible antagonism of actionGalantamine	Possible antagonism of actionMetrizamide	Increased risk of convulsions 
     | 
   
  
   
    CYP450  Drug Interaction | 
    
      [CYP450 TableÁ÷Á¢Á¶È¸] ethanol¿¡ ´ëÇÑ P450 table
  SUBSTRATES 
CYP 2E1 
acetaminophen 
chlorzoxazone 
**ethanol** 
 INHIBITORS 
CYP 2E1 
disulfiram 
 INDUCERS 
CYP 2E1 
**ethanol** 
isoniazid 
  SUBSTRATES 
CYP 2E1 
acetaminophen 
chlorzoxazone 
**ethanol** 
 INHIBITORS 
CYP 2E1 
disulfiram 
 INDUCERS 
CYP 2E1 
**ethanol** 
isoniazid 
     | 
   
  
   
    | Food Interaction | 
    
       Ginseng¿¡ ´ëÇÑ Food Interaction Á¤º¸ Not Available 
     | 
   
  
   
    | Drug Target | 
    
      
      [Drug Target]
     | 
   
  
   
    | Description | 
    
       ethanol¿¡ ´ëÇÑ Description Á¤º¸ A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages. [PubChem]
  Ginseng¿¡ ´ëÇÑ Description Á¤º¸ Ginseng is promoted as an adaptogen (a product that increases the body's resistance to stress), one which can to a certain extent be supported with reference to its anticarcinogenic and antioxidant properties. Ginseng is also known to contain phytoestrogens. 
     | 
   
  
   
    | Dosage Form | 
    
       ethanol¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Aerosol	TopicalGel	TopicalLiquid	IntramuscularLiquid	IntravenousLiquid	OralLiquid	TopicalLotion	TopicalSolution	TopicalSolution / drops	OralSpray	Topical
  Ginseng¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Capsule	OralLiquid	OralSolution / drops	OralTablet	Oral 
     | 
   
  
   
    | Drug Category | 
    
       ethanol¿¡ ´ëÇÑ Drug_Category Á¤º¸ Anti-Infective Agents, LocalCentral Nervous System DepressantsDisinfectantsSolvents
  Ginseng¿¡ ´ëÇÑ Drug_Category Á¤º¸ Not Available 
     | 
   
  
   
    | Smiles String Canonical | 
    
       ethanol¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CCO
  Ginseng¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ Not Available
  Ginseng¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ Not Available 
     | 
   
  
   
    | Smiles String Isomeric | 
    
       ethanol¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CCO
  Ginseng¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ Not Available 
     | 
   
  
   
    | InChI Identifier | 
    
       ethanol¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ Not Available
  Ginseng¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ Not Available 
     | 
   
  
   
    | Chemical IUPAC Name | 
    
       ethanol¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ ethanol
  Ginseng¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ Not Available 
     | 
   
  
   
    | Drug-Induced Toxicity Related Proteins | 
    
      ETHANOL ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Proenkephalin  Drug:ethanol Toxicity:ethanol narcosis.  [¹Ù·Î°¡±â] Replated Protein:Insulin receptor substrate 1 Drug:Ethanol  Toxicity:impair liver regeneration, inhibit DNA synthesis, and mute cellular responses to growth factor stimulation.  [¹Ù·Î°¡±â] Replated Protein:Phosphatidylinositol-4-phosphate 3-kinase Drug:Ethanol  Toxicity:impair liver regeneration, inhibit DNA synthesis, and mute cellular responses to growth factor stimulation.  [¹Ù·Î°¡±â] Replated Protein:Insulin receptor substrate 2 Drug:Ethanol  Toxicity:impair liver regeneration, inhibit DNA synthesis, and mute cellular responses to growth factor stimulation.  [¹Ù·Î°¡±â] Replated Protein:Mitogen-activated protein kinase(Erk2) Drug:Ethanol  Toxicity:impair liver regeneration, inhibit DNA synthesis, and mute cellular responses to growth factor stimulation.  [¹Ù·Î°¡±â] Replated Protein:Mitogen-activated protein kinase  Drug:Ethanol  Toxicity:impair liver regeneration, inhibit DNA synthesis, and mute cellular responses to growth factor stimulation.  [¹Ù·Î°¡±â] UREA ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Parathyroid hormone Drug:urea Toxicity:chronic renal failure.  [¹Ù·Î°¡±â] 
     | 
   
    
  |  
	   
	   
	
	  
       |  
	    
	      
	        
            
                | »ç¿ëÀÚÄÁÅÙÃ÷ | 
                             
	         
	       | 
	           	  
       |  
	     |  
	   
	     	
 
  | 
   
   
     | 
   
  
    
      
        
          
            
              - 
                ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2022-03-15
              
 
              - 
                
                º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
                
              
     
             
         |                 
       
     |       
          
                
                    
                       ¾Ë¸² | 
                       
                      »ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.  | 
                    
                    | 
               
      
      
                
                    
                       °æ°í | 
                     
                      µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. 
                          Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â 
                          Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
                            ¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
                          ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
 | 
                    
                    | 
               
  
 
  
    ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é 
    ¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
   
  
 
  º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
 
 |  
             
             | 
         
         
         | 
         |